Back to Browse Journals » Pathology and Laboratory Medicine International » Volume 3

Fibrous dysplasia of bone: a clinicopathologic review

Authors Mohan H, Mittal P, Mundi I, Kumar S

Published Date November 2011 Volume 2011:3 Pages 31—42

DOI http://dx.doi.org/10.2147/PLMI.S24866

Published 8 November 2011

Harsh Mohan1, Preeti Mittal1, Irneet Mundi1, Sudhir Kumar2
1Department of Pathology, 2Department of Orthopedics, Government Medical College, Sector 32, Chandigarh, India

Abstract: Fibrous dysplasia of the bones is an uncommon congenital skeletal disorder that is found equally in both genders and is not inherited. Its etiology has been linked to an activating mutation of Gsα and the downstream effects of the resultant increase in cAMP. Fibrous dysplasia is categorized as either monostotic or polyostotic, and may occur as a component of McCune-Albright syndrome or the rare Mazabraud syndrome. Long bones, skull bones, and ribs are the most commonly affected bones. The radiological picture is somewhat variable, including a ground-glass appearance, expansion of the bone, and sclerosis surrounding the lesion. Histologically, fibrous dysplasia shows irregularly-shaped trabeculae of immature, woven bone in a background of variably cellular, loosely arranged fibrous stroma. It may be complicated by pathologic fracture, and rarely by malignant transformation. This review examines interesting issues surrounding the etiology of fibrous dysplasia, its clinical and laboratory manifestations, radiological picture, utility of bone biopsy, gross and microscopic pathology, complications, and its differential diagnostic considerations.

Keywords: fibrous dysplasia, McCune-Albright syndrome, monostotic form, polyostotic form

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Visual fields in a chloroquine treatment

García-Domene MC, Díez-Ajenjo MA, de Fez MD, Luque MJ

Clinical Optometry 2014, 6:59-70

Published Date: 30 September 2014

Visual performance and aberration associated with contact lens wear in patients with keratoconus: a pilot study

Abdu M, Mohidin N, Mohd-Ali B

Clinical Optometry 2014, 6:47-57

Published Date: 16 August 2014

Differences in daily disposable circle lens performance characteristics

Schafer JM, Reindel WT, Rah MJ, Chan O, Zhang L

Clinical Optometry 2014, 6:37-42

Published Date: 3 April 2014

Preservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension

Lanzl I, Hamacher T, Rosbach K, Ramez MO, Rothe R, Růžičková E, Karhanová M, Kimmich F

Clinical Ophthalmology 2013, 7:901-910

Published Date: 16 May 2013

Therapeutic efficiency of folated poly(ethylene glycol)-chitosan-graft-polyethylenimine-Pdcd4 complexes in H-ras12V mice with liver cancer

Kim YK, Minai-Tehrani A, Lee JH, Cho CS, Cho MH, Jiang HL

International Journal of Nanomedicine 2013, 8:1489-1498

Published Date: 16 April 2013

Reinventing your primary care practice: becoming an MDCEO™

Conard SE, Courtney MR

Journal of Healthcare Leadership 2013, 5:1-8

Published Date: 7 March 2013

Mirtogenol® potentiates latanoprost in lowering intraocular pressure and improves ocular blood flow in asymptomatic subjects

Robert D Steigerwalt Jr, Gianni Belcaro, Paolo Morazzoni, et al

Clinical Ophthalmology 2010, 4:471-476

Published Date: 12 May 2010